Authors


Natasha Blakeney, MPH

Latest:

Making a Difference in Cancer Trials Accrual

The integration of pre-screening all patients for eligibility in oncology studies.


CluePoints

Latest:

Case Study: Confirmation of Fraud - Diaries Completed by Staff

In a phase III trial in vascular disease, over 4,500 patients were randomized across 160 sites.


Rickie Stevens

Latest:

A Different Approach to CTMS

In order to manage critical clinical trial information, sponsors and CROs typically implement a strict data management structure...


Michael O’Kelly

Latest:

Lifecycle Modeling and Simulation in Clinical Trials

How the application of evolving M&S models are transforming full-research design strategies.


William Curatolo

Latest:

Artisanal Publishing

In my previous blog "From Science to Fiction" (ACTO, April 15, 2014), I discussed the trials and tribulations of unlearning the scientific writing style...


Marie A. Daleo

Latest:

Optimizing Clinical Trial Enrollment Methods Through "Goal Programming"

Clinical trials often fail to reach desired goals due to poor recruitment outcomes, including low participant turnout, high recruitment cost, or poor representation of minorities.


Jorge G. Guerra, MD

Latest:

From Telex to Terabytes: Using Technology to Optimize Clinical Operations

As a principal investigator in the early 1980s at University Hospital in Peru, I used to receive instructions and queries from the study team through a Telex machine.



Ulrich Raeth, MD

Latest:

Cancer Trials: Raising Accrual Rates

Lessons learned from the recruitment of colorectal cander patients into clinical trials.


Kerry Dyson

Latest:

Research in the United Kingdom

The current initiatives and a historical overview of the clinical trial landscape.


Robb Giddings

Latest:

Clinical Contracting Efficiency

A simple but overlooked way to save millions of dollars during new drug development.


Andrew Garrett

Latest:

Lifecycle Modeling and Simulation in Clinical Trials

How the application of evolving M&S models are transforming full-research design strategies.


N. Seth Berry

Latest:

Lifecycle Modeling and Simulation in Clinical Trials

How the application of evolving M&S models are transforming full-research design strategies.


Audrius Sveikata

Latest:

Clinical Trials in the Baltic States

The region has an appropriate population size, solid infrastructure, experienced nvestigators, and short timelines.


Sheila Mikhail

Latest:

Clinical Contracting Efficiency

A simple but overlooked way to save millions of dollars during new drug development.


Mark M. Engelhart

Latest:

Performance Metrics: Optimizing Outcomes

A clearly defined set of performance measures is an integral part of the central laboratory selection and management process.



Rahlyn Gossen

Latest:

What Google Can Teach Us About Trial Education, Awareness

Search-engine data offers window to public consciousness around clinical trial research, participation.



Leslie Cho, MD, FACC

Latest:

The Use of a Single Center, Multi-Location Research Structure For Participation in Large Clinical Trials: The Cleveland Clinic Model

As funding for clinical research trials decreases and sponsors of clinical studies are under increasingly stringent timelines to obtain FDA approval and get new therapies to market, the need increases for well-managed, efficient, and effective clinical trial sites.


Honorio Silva, MD

Latest:

Moving From Compliance to Competency: A Harmonized Core Competency Framework for the Clinical Research Professional

Medicines development and clinical research are among the most heavily regulated activities on a global basis.


Lisa Howe, MsC

Latest:

Clinical Trials and Social Networking

There are significant challenges facing the pharmaceutical and contract research organization (CRO) industries in relation to patient recruitment of clinical trials and the need to implement new strategies to finally overcome what has been called ‘the most difficult and challenging aspect of clinical trials.’


Jennifer Sodrel

Latest:

Innovation in Ethical Review

Going paperless can help an IRB quickly collaborate, share documents, and review protocols.


Jim Moran

Latest:

Steps for a Successful Clinical Trial Management System

As the importance of translational research continues to grow, research institutions are exploring other options to remain competitive players in the academic clinical research arena.


Matthew Do

Latest:

Best Practices in IRT Implementation: A Checklist for Asia-Pac

Pharmaceutical sponsors conducting clinical trials in the Asia Pacific region have a rare opportunity at hand...


Mary Jane Lunsford

Latest:

Common Technical Document Development

Partnership formation is the new trend in common technical document development.


Neil Weisman

Latest:

Bridging the Disconnect in Pediatric Clinical Trial Recruitment

Despite the growing need for pediatric-approved medications, clinical trial enrollment for pediatrics remains challenging.


Courtney McBean

Latest:

5 Essential Cornerstones of RbM Technology

Often overlooked in early evaluation of RBM are the tools and technologies required for successful implementation. Without the right tools to track and prioritize the shift from traditional monitoring to RBM, successful implementation is doubtful, posing detrimental consequences not only for the monitors, but also the overall trial.


David Shoemaker, PhD

Latest:

The Gene Therapy Product Development Process

Navigating the many complexities in clinical trials, manufacturing, and regulatory interaction in moving gene therapies from development to market.


Andrew J. Sandgren

Latest:

Enhancing Trial Enrollment Through 'Goal Programming'

How iterative analysis of subject recruitment data can optimize outcomes during ongoing enrollment.

© 2024 MJH Life Sciences

All rights reserved.